Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 SEK | 0.00% | +1.91% | -18.88% |
04-25 | Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-27 | Enzymatica AB Announces Composition of Nomination Committee | CI |
Business Summary
Number of employees: 16
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices
100.0
%
| 49 | 100.0 % | 51 | 100.0 % | +4.00% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
65.4
%
| 25 | 51.3 % | 33 | 65.4 % | +32.66% |
Europe
30.8
%
| 15 | 30.4 % | 16 | 30.8 % | +5.47% |
Rest of the World
3.8
%
| 9 | 18.3 % | 2 | 3.8 % | -78.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulf Thomas Blom
FOU | Founder | 59 | 31/12/06 |
Claus Egstrand
CEO | Chief Executive Officer | 63 | 17/07/17 |
Director of Finance/CFO | 55 | 31/12/17 | |
Chief Tech/Sci/R&D Officer | 57 | 31/12/15 | |
Chief Operating Officer | 56 | 31/12/20 | |
Johan Lindvall
PRN | Corporate Officer/Principal | 54 | 13/07/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bengt Baron
CHM | Chairman | 62 | 18/12/16 |
Director/Board Member | 56 | 14/02/16 | |
Director/Board Member | 57 | 30/04/21 | |
Ulf Thomas Blom
FOU | Founder | 59 | 31/12/06 |
Louise Nicolin
BRD | Director/Board Member | 51 | 18/12/16 |
Director/Board Member | 69 | 18/12/16 | |
Moa Fransson
BRD | Director/Board Member | - | 30/04/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 173,382,220 | 68,184,238 ( 39.33 %) | 0 | 39.33 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Enzymatica Care AB
|
Sector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.88% | 51.93M | |
+35.01% | 709B | |
+30.71% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.40% | 239B | |
+9.30% | 211B | |
-3.44% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- ENZY Stock
- Company Enzymatica AB